Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 14h ago.
Showing the 25 most recent actions.
| $1,150 |
| 1d ago |
| UBERUber Technologies, Inc. | Wedbush | Reiterated | Outperform | $91 | 1d ago |
| ARGXargenx SE | Wedbush | Reiterated | Outperform | $1,150 | 6d ago |
| NTAPNetApp, Inc. | Wedbush | Maintained | Neutral | $150 $170 | 6d ago |
| VRSNVeriSign, Inc. | Wedbush | Maintained | Outperform | $324 $341 | Sep 1 |
| ASNDAscendis Pharma A/S | Wedbush | Reiterated | Outperform | $327 | Sep 1 |
| NVDANVIDIA Corporation | Wedbush | Maintained | Outperform | $330 $345 | Aug 27 |
| SYRESpyre Therapeutics, Inc. | Wedbush | Maintained | Outperform | $130 $123 | Aug 26 |
| DASHDoorDash, Inc. | Wedbush | Maintained | Neutral | $205 $220 | Aug 20 |
| WIXWix.com Ltd. | Wedbush | Maintained | Neutral | $55 $80 | Aug 20 |
| DUOLDuolingo, Inc. | Wedbush | Maintained | Neutral | $139 $150 | Aug 20 |
| EXPEExpedia Group, Inc. | Wedbush | Maintained | Outperform | $334 $417 | Aug 20 |
| EBAYeBay Inc. | Wedbush | Maintained | Outperform | $135 $137 | Aug 20 |
| TLXTelix Pharmaceuticals Limited | Wedbush | Reiterated | Outperform | $22 | Aug 20 |
| ARGXargenx SE | Wedbush | Maintained | Outperform | $1,050 $1,150 | Aug 18 |
| VERAVera Therapeutics, Inc. | Wedbush | Reiterated | Neutral | $34 | Aug 17 |
| SNDKSandisk Corporation | Wedbush | Reiterated | Outperform | $2,000 | Aug 14 |
| FATEFate Therapeutics, Inc. | Wedbush | Reiterated | Outperform | $7 | Aug 14 |
| CBRSCerebras Systems Inc. | Wedbush | Maintained | Outperform | $280 $290 | Aug 13 |
| COAGHemab Therapeutics Holdings, Inc. | Wedbush | Maintained | Outperform | $55 $64 | Aug 12 |
| ORKAOruka Therapeutics, Inc. | Wedbush | Reiterated | Outperform | $165 | Aug 11 |
| SIONSionna Therapeutics, Inc. | Wedbush | Downgraded from Outperform | Neutral | $53 $5 | Aug 11 |
| VERAVera Therapeutics, Inc. | Wedbush | Maintained | Neutral | $43 $34 | Aug 11 |